HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC
Journal for ImmunoTherapy of Cancer · 2026-09 · 14 (9) · e014772
DOI: 10.1136/jitc-2026-014772 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 08.09.2026. Verfasst von Yaoyao Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laborat…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutrophils, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Postdoctoral Program for Innovative Talents, National Natural Science Foundation of China, Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
Non-small cell lung cancer (NSCLC) is one of the frequently occurring cancers characterized by molecular heterogeneity and multiple immune cell infiltration patterns, which are associated with treatment sensitivity and resistance. However, the specific microenvironmental cells and their mechanisms that lead to treatment resistance in patients need to be explored in greater depth.
Methods
On the basis of patients receiving neoadjuvant therapy in our center, a multicenter, multicohort NSCLC spatial transcriptome, single-cell transcriptome, T-cell receptor repertoire sequencing, bulk RNA transcriptome, phosphorylated proteome, genome mutation, and clinical data were included for a comprehensive assessment of the therapeutic and prognostic impact of HIF1A + CSF3R + neutrophils in NSCLC. In vitro experiments validated the functional phenotype of HIF1A + CSF3R + neutrophils and co-localization interactions with other cellular subpopulations. Gradient boosting machine (GBM) constructed region of interest (ROI) models for evaluation. Computer-aided drug design (CADD) was used to predict targeted small molecule drugs, and in vivo mouse models were constructed to assess the effectiveness of the combination treatment regimen.
Results
Centered on HIF1A + CSF3R + neutrophils, recruited exhausted T cells and stromal cells form a hypoxic niche within the tumor region, which was enriched in non-response patients. ROI composed of these specific cellular subpopulations, associated with senescence and glycolysis, accurately predicting NSCLC progression, prognosis, and microenvironment composition. CADD analysis identified that platycodin-D2 specifically targeted CSF3R, reducing HIF1A expression and inhibiting neutrophil activity. Combining navitoclax, platycodin-D2 with anti-programmed cell death protein 1 (PD-1) significantly suppressed tumor proliferation and improved the immunosuppressive microenvironment.
Conclusion
Our study emphasized the role of HIF1A + CSF3R + neutrophils in immunotherapeutic resistance of NSCLC, constructed a microenvironmental immune dysregulation network in a hypoxic ecological niche with HIF1A + CSF3R + neutrophils as the center. Platycodin-D2 specifically targeted HIF1A + CSF3R + neutrophils, enhancing the efficacy of anti-PD-1 therapy in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, State Key Laboratory of Druggability Evaluati…
- Pancreas Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key L…
- Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Department of Molecular Im…
- Department of Minimally Invasive Esophageal Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Labor…
- Department of Biomedical Sciences, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, 13200 Kepala Batas, State of Penang, Malaysia yli08@tmu.edu.cn zhanghaolingedu@163.com 2335940013@qq.com chenzuoyu24@…
Förderung
- National Postdoctoral Program for Innovative Talents
- National Natural Science Foundation of China
- Postdoctoral Science Foundation
Zitieren
APA
Zhou, Y., Liu, Z., Kaysar, P., Han, Y., Ma, Y., Yu, X., Ni, B., Chen, Z., Xie, Y., Zhang, H., & Li, Y. (2026). HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. Journal for ImmunoTherapy of Cancer, 14(9), e014772. https://doi.org/10.1136/jitc-2026-014772
Vancouver
Zhou Y, Liu Z, Kaysar P, Han Y, Ma Y, Yu X, et al. HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. Journal for ImmunoTherapy of Cancer. 2026;14(9):e014772. doi:10.1136/jitc-2026-014772
BibTeX
@article{Zhou2026,
author = {Zhou, Yaoyao and Liu, Ziyun and Kaysar, Parhat and Han, Yuxi and Ma, Yijian and Yu, Xiaozhou and Ni, Bo and Chen, Zuoyu and Xie, Yongjie and Zhang, Haoling and Li, Yueguo},
title = {HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {9},
pages = {e014772},
doi = {10.1136/jitc-2026-014772}
}
EUVIMED